Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Cornelissen

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Respiratory Research|November 23, 2018
Nebulization versus standard application for topical anaesthesia during flexible bronchoscopy under moderate sedation - a randomized controlled trialTobias Müller, Christian Cornelissen, Michael Dreher
BMC Neurology|August 10, 2016
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimodTjalf Ziemssen, Raimar Kern, Christian Cornelissen
BMC Neurology|June 19, 2015
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practiceTjalf Ziemssen, Raimar Kern, Christian Cornelissen
Medizinische Klinik (Munich, Germany : 1983)|December 30, 2009
[Uhl's disease--rare cause of chronic right heart failure]Christian Cornelissen, Dirk Frechen, Karin Schreiner, et al.
BMC Molecular Biology|February 25, 2011
TGFβ1 enhances MAD1 expression and stimulates promoter-bound Pol II phosphorylation: basic functions of C/EBP, SP and SMAD3 transcription factorsNadine Hein, Kan Jiang, Christian Cornelissen, et al.
European Journal of Cell Biology|October 11, 2011
Signaling by IL-31 and functional consequencesChristian Cornelissen, Juliane Lüscher-Firzlaff, Jens Malte Baron, et al.
International Journal of Molecular Sciences|March 28, 2013
Cytokines and the skin barrierKai H Hänel, Christian Cornelissen, Bernhard Lüscher, et al.
Plos One|May 6, 2017
Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARLJonathan Alsop, Jennie Medin, Christian Cornelissen, et al.
Journal of Neurology|December 19, 2019
Differentiating societal costs of disability worsening in multiple sclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Journal of Neurology|January 18, 2020
Correction to: Differentiating societal costs of disability worsening in multiple sclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Respiratory Research|November 23, 2018
Nebulization versus standard application for topical anaesthesia during flexible bronchoscopy under moderate sedation - a randomized controlled trialTobias Müller, Christian Cornelissen, Michael Dreher
BMC Neurology|August 10, 2016
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimodTjalf Ziemssen, Raimar Kern, Christian Cornelissen
BMC Neurology|June 19, 2015
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practiceTjalf Ziemssen, Raimar Kern, Christian Cornelissen
Medizinische Klinik (Munich, Germany : 1983)|December 30, 2009
[Uhl's disease--rare cause of chronic right heart failure]Christian Cornelissen, Dirk Frechen, Karin Schreiner, et al.
BMC Molecular Biology|February 25, 2011
TGFβ1 enhances MAD1 expression and stimulates promoter-bound Pol II phosphorylation: basic functions of C/EBP, SP and SMAD3 transcription factorsNadine Hein, Kan Jiang, Christian Cornelissen, et al.
European Journal of Cell Biology|October 11, 2011
Signaling by IL-31 and functional consequencesChristian Cornelissen, Juliane Lüscher-Firzlaff, Jens Malte Baron, et al.
International Journal of Molecular Sciences|March 28, 2013
Cytokines and the skin barrierKai H Hänel, Christian Cornelissen, Bernhard Lüscher, et al.
Plos One|May 6, 2017
Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARLJonathan Alsop, Jennie Medin, Christian Cornelissen, et al.
Journal of Neurology|December 19, 2019
Differentiating societal costs of disability worsening in multiple sclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Journal of Neurology|January 18, 2020
Correction to: Differentiating societal costs of disability worsening in multiple sclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Pageof 4